Dimethyl fumarate Accord Unia Europejska - polski - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - fumaran dimetylu - multiple sclerosis, relapsing-remitting; multiple sclerosis - leki immunosupresyjne - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dabigatran Etexilate Accord Unia Europejska - polski - EMA (European Medicines Agency)

dabigatran etexilate accord

accord healthcare s.l.u. - za pomocą dabigatran mesylate - venous thromboembolism; arthroplasty, replacement - Środki przeciwzakrzepowe - prevention of venous thromboembolic events.

Tolvaptan Accord Unia Europejska - polski - EMA (European Medicines Agency)

tolvaptan accord

accord healthcare s.l.u. - Толваптан - niewłaściwy zespół adh - leki moczopędne, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).